Co-targeting CDK4/6 and AKT with endocrine therapy overcomes CDK4/6 inhibitor and endocrine therapy resistance in preclinical breast cancer models

101Smart Ltd.
09:15 - 09:40 Back to programme

Speakers

Henrik Ditzel
Head of Research, University of Southern Denmark and Odense University Hospital